国泰创新药ETF联接A(014117)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
10,028.63 |
413,472.80 |
20,507.53 |
58,262.40 |
| 存出保证金 |
7,646.06 |
15,771.04 |
4,604.57 |
3,743.93 |
| 交易性金融资产 |
105,426,730.20 |
102,796,930.14 |
44,062,258.73 |
61,232,474.04 |
| 其中：股票投资 |
318,345.00 |
- |
- |
33,055.16 |
| 债券投资 |
607,623.45 |
1,414,764.17 |
200,683.73 |
304,259.18 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
3,031,955.52 |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
1,771,318.99 |
104,976.73 |
368,061.77 |
522,127.42 |
| 其他资产 |
70,469.70 |
- |
- |
49,299.34 |
| 资产总计 |
114,763,276.28 |
111,588,819.74 |
47,310,153.56 |
66,296,467.03 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
314,780.81 |
- |
- |
- |
| 应付赎回款 |
1,545,662.02 |
4,332,182.45 |
159,970.63 |
808,771.69 |
| 应付管理人报酬 |
3,076.74 |
3,262.99 |
1,303.21 |
2,242.49 |
| 应付托管费 |
615.37 |
652.61 |
260.63 |
448.48 |
| 应付销售服务费 |
21,362.33 |
24,176.78 |
8,114.85 |
11,435.99 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
109,841.42 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
74,924.76 |
113,553.52 |
58,745.56 |
29,045.76 |
| 负债合计 |
2,070,263.45 |
4,473,828.35 |
228,394.88 |
851,944.41 |
| 所有者权益 |
| 实收基金 |
161,736,012.66 |
191,531,256.88 |
97,398,773.39 |
99,209,238.69 |
| 未分配利润 |
-49,042,999.83 |
-84,416,265.49 |
-50,317,014.71 |
-33,764,716.07 |
| 所有者权益合计 |
112,693,012.83 |
107,114,991.39 |
47,081,758.68 |
65,444,522.62 |
| 负债及所有者权益总计 |
114,763,276.28 |
111,588,819.74 |
47,310,153.56 |
66,296,467.03 |
欢迎访问证券之星！请点此与我们联系 版权所有： Copyright © 1996-年
微信公众号
证券之星APP
基本资料
